mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.0064 |
0.8 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0097 |
0.8 |